SPHERE Per-AF Post-Approval Study

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 25, 2025

Primary Completion Date

October 31, 2030

Study Completion Date

October 31, 2030

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

Sphere-9™ Catheter and Affera™ Ablation System

De novo pulmonary vein isolation procedure using commercially available Sphere-9™ Catheter and Affera™ Ablation System

Trial Locations (6)

10467

RECRUITING

Montefiore Medical Center, New York

15212

RECRUITING

Allegheny General Hospital, Pittsburgh

18901

RECRUITING

Doylestown Health Cardiology, Doylestown

22903

RECRUITING

University of Virginia Medical Center, Charlottesville

24501

RECRUITING

Centra Medical Group Stroobants Cardiovascular Center, Lynchburg

77030

RECRUITING

Houston Methodist Hospital, Houston

All Listed Sponsors
lead

Medtronic Cardiac Ablation Solutions

INDUSTRY

NCT06858306 - SPHERE Per-AF Post-Approval Study | Biotech Hunter | Biotech Hunter